A new milestone for CRISPR: prime editing enters clinical trials, enabling precise, programmable DNA changes for treating ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...

Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston ...

Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

A newly discovered bacterial defense protein named Cat1 reveals an extraordinary method of viral neutralization. All living ...

Researchers have found a promising new method for gene therapy. They successfully restarted inactive genes by bringing them ...

They also found that after the extra chromosome was removed, genes tied to nervous system development were more active and ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $33.11, a high estimate of $68.00, ...

One way would be to ensure there is a consistent and predictable yield year by year. For two years in a row, beginning in the ...

The clinical-stage biotech is developing gene-editing CRISPR technology. Editas has reported encouraging testing results in ...